SMO-话题@MedSci

#SMO#

285篇内容 | 3666人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2024760, encodeId=4b0a2024e60d0, content=<a href='/topic/show?id=c27516459de' target=_blank style='color:#2F92EE;'>#SMO#</a>, objectTitle=2016MASCC/ESMO共识建议——高催吐风险化疗恶心呕吐的预防（更新）发布, objectType=article, longId=73707, objectId=e887e37075c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e887e37075c, replyNumber=0, likeNumber=79, createdTime=2017-03-08, rootId=0, userName=liuhuangbo, userId=6779163, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e887e37075c, moduleTitle=2016MASCC/ESMO共识建议——高催吐风险化疗恶心呕吐的预防（更新）发布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e887e37075c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2024782, encodeId=98582024e828d, content=<a href='/topic/show?id=c27516459de' target=_blank style='color:#2F92EE;'>#SMO#</a>, objectTitle=ESMO 2016：nivolumab辅助治疗可切除的非小细胞肺癌, objectType=article, longId=79650, objectId=927ce96505f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=927ce96505f, replyNumber=0, likeNumber=71, createdTime=2017-02-05, rootId=0, userName=liuhuangbo, userId=6779163, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=927ce96505f, moduleTitle=ESMO 2016：nivolumab辅助治疗可切除的非小细胞肺癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=927ce96505f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2024761, encodeId=aa262024e619d, content=<a href='/topic/show?id=c27516459de' target=_blank style='color:#2F92EE;'>#SMO#</a>, objectTitle=2013ESMO临床实践指南：妊娠滋养细胞疾病的诊断、治疗与随访发布, objectType=article, longId=74758, objectId=544ae47586f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=544ae47586f, replyNumber=0, likeNumber=19, createdTime=2016-08-09, rootId=0, userName=liuhuangbo, userId=6779163, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=544ae47586f, moduleTitle=2013ESMO临床实践指南：妊娠滋养细胞疾病的诊断、治疗与随访发布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=544ae47586f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2024777, encodeId=703f2024e776e, content=<a href='/topic/show?id=c27516459de' target=_blank style='color:#2F92EE;'>#SMO#</a>, objectTitle=ESMO 2016：Alisertib治疗神经内分泌前列腺癌, objectType=article, longId=79627, objectId=1b09e962777, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1b09e962777, replyNumber=0, likeNumber=68, createdTime=2017-03-29, rootId=0, userName=liuhuangbo, userId=6779163, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1b09e962777, moduleTitle=ESMO 2016：Alisertib治疗神经内分泌前列腺癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1b09e962777)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2024772, encodeId=ad8a2024e7217, content=<a href='/topic/show?id=c27516459de' target=_blank style='color:#2F92EE;'>#SMO#</a>, objectTitle=2016ESMO临床诊疗指南——胆管癌的诊断、治疗与随访发布, objectType=article, longId=78935, objectId=642ae893509, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=642ae893509, replyNumber=0, likeNumber=21, createdTime=2017-07-28, rootId=0, userName=liuhuangbo, userId=6779163, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=642ae893509, moduleTitle=2016ESMO临床诊疗指南——胆管癌的诊断、治疗与随访发布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=642ae893509)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2024775, encodeId=7c042024e7510, content=<a href='/topic/show?id=c27516459de' target=_blank style='color:#2F92EE;'>#SMO#</a>, objectTitle=ESMO 2016：奥拉帕尼能否改善胃癌患者的总生存期？（GOLD试验）, objectType=article, longId=79623, objectId=aa97e962349, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=aa97e962349, replyNumber=0, likeNumber=61, createdTime=2017-03-17, rootId=0, userName=liuhuangbo, userId=6779163, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=aa97e962349, moduleTitle=ESMO 2016：奥拉帕尼能否改善胃癌患者的总生存期？（GOLD试验）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=aa97e962349)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2024783, encodeId=ef7f2024e8370, content=<a href='/topic/show?id=c27516459de' target=_blank style='color:#2F92EE;'>#SMO#</a>, objectTitle=ESMO 2016：卡铂+培美曲塞+派姆单抗，可改善NSCLC患者的PFS, objectType=article, longId=79863, objectId=3fa9e98630a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3fa9e98630a, replyNumber=0, likeNumber=86, createdTime=2017-05-04, rootId=0, userName=liuhuangbo, userId=6779163, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3fa9e98630a, moduleTitle=ESMO 2016：卡铂+培美曲塞+派姆单抗，可改善NSCLC患者的PFS, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3fa9e98630a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2024776, encodeId=1cf22024e7656, content=<a href='/topic/show?id=c27516459de' target=_blank style='color:#2F92EE;'>#SMO#</a>, objectTitle=ESMO 2016：Niraparib可延长复发性卵巢癌患者的PFS, objectType=article, longId=79625, objectId=03fde96257d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=03fde96257d, replyNumber=0, likeNumber=62, createdTime=2017-06-16, rootId=0, userName=liuhuangbo, userId=6779163, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=03fde96257d, moduleTitle=ESMO 2016：Niraparib可延长复发性卵巢癌患者的PFS, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=03fde96257d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2024766, encodeId=24ce2024e6650, content=<a href='/topic/show?id=c27516459de' target=_blank style='color:#2F92EE;'>#SMO#</a>, objectTitle=2016ESMO临床诊疗指南——新诊断和复发性滤泡性淋巴瘤的诊断、治疗与随访发布, objectType=article, longId=78484, objectId=c96ee84848f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c96ee84848f, replyNumber=0, likeNumber=15, createdTime=2017-03-25, rootId=0, userName=liuhuangbo, userId=6779163, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c96ee84848f, moduleTitle=2016ESMO临床诊疗指南——新诊断和复发性滤泡性淋巴瘤的诊断、治疗与随访发布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c96ee84848f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2024774, encodeId=3eb82024e74cb, content=<a href='/topic/show?id=c27516459de' target=_blank style='color:#2F92EE;'>#SMO#</a>, objectTitle=ESMO 2016：氟维司群可延长乳腺癌患者的无进展生存期（FALCON试验）, objectType=article, longId=79621, objectId=d717e96216e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d717e96216e, replyNumber=0, likeNumber=67, createdTime=2017-01-29, rootId=0, userName=liuhuangbo, userId=6779163, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d717e96216e, moduleTitle=ESMO 2016：氟维司群可延长乳腺癌患者的无进展生存期（FALCON试验）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d717e96216e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2024771, encodeId=abc42024e712d, content=<a href='/topic/show?id=c27516459de' target=_blank style='color:#2F92EE;'>#SMO#</a>, objectTitle=2016ESMO临床实践指南——转移性非小细胞肺癌的诊断、治疗和随访发布, objectType=article, longId=78694, objectId=ac50e8694d5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ac50e8694d5, replyNumber=0, likeNumber=17, createdTime=2017-07-19, rootId=0, userName=liuhuangbo, userId=6779163, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ac50e8694d5, moduleTitle=2016ESMO临床实践指南——转移性非小细胞肺癌的诊断、治疗和随访发布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ac50e8694d5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2024762, encodeId=900f2024e62d9, content=<a href='/topic/show?id=c27516459de' target=_blank style='color:#2F92EE;'>#SMO#</a>, objectTitle=2016MASCC/ESMO共识建议——中度致吐化疗恶心呕吐的治疗发布, objectType=article, longId=75277, objectId=f7a5e527789, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f7a5e527789, replyNumber=0, likeNumber=19, createdTime=2016-11-13, rootId=0, userName=liuhuangbo, userId=6779163, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f7a5e527789, moduleTitle=2016MASCC/ESMO共识建议——中度致吐化疗恶心呕吐的治疗发布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f7a5e527789)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2024780, encodeId=a2ed2024e8022, content=<a href='/topic/show?id=c27516459de' target=_blank style='color:#2F92EE;'>#SMO#</a>, objectTitle=ESMO 2016：ANG1005可通过血脑屏障，治疗脑转移瘤, objectType=article, longId=79644, objectId=7474e9644c6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7474e9644c6, replyNumber=0, likeNumber=79, createdTime=2017-03-08, rootId=0, userName=liuhuangbo, userId=6779163, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7474e9644c6, moduleTitle=ESMO 2016：ANG1005可通过血脑屏障，治疗脑转移瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7474e9644c6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2024768, encodeId=93742024e6895, content=<a href='/topic/show?id=c27516459de' target=_blank style='color:#2F92EE;'>#SMO#</a>, objectTitle=2016ESMO临床实践指南——食管癌的诊断，治疗及随访发布, objectType=article, longId=78604, objectId=c2dae860466, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c2dae860466, replyNumber=0, likeNumber=21, createdTime=2016-10-14, rootId=0, userName=liuhuangbo, userId=6779163, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c2dae860466, moduleTitle=2016ESMO临床实践指南——食管癌的诊断，治疗及随访发布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c2dae860466)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2024786, encodeId=24672024e86f2, content=<a href='/topic/show?id=c27516459de' target=_blank style='color:#2F92EE;'>#SMO#</a>, objectTitle=2016ESMO临床诊疗指南——BRCA突变携带者以及其他乳腺/卵巢遗传性癌症综合征的预防和筛查发布, objectType=article, longId=80002, objectId=6d9a8000242, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6d9a8000242, replyNumber=0, likeNumber=19, createdTime=2017-05-15, rootId=0, userName=liuhuangbo, userId=6779163, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6d9a8000242, moduleTitle=2016ESMO临床诊疗指南——BRCA突变携带者以及其他乳腺/卵巢遗传性癌症综合征的预防和筛查发布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6d9a8000242)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2024764, encodeId=c24c2024e64e2, content=<a href='/topic/show?id=c27516459de' target=_blank style='color:#2F92EE;'>#SMO#</a>, objectTitle=2016MASCC/ESMO共识建议——催吐药风险分类及抗肿瘤药物致吐性评估发布, objectType=article, longId=76273, objectId=3d4be6273e6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3d4be6273e6, replyNumber=0, likeNumber=31, createdTime=2017-04-11, rootId=0, userName=liuhuangbo, userId=6779163, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3d4be6273e6, moduleTitle=2016MASCC/ESMO共识建议——催吐药风险分类及抗肿瘤药物致吐性评估发布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3d4be6273e6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2024769, encodeId=cc5c2024e690c, content=<a href='/topic/show?id=c27516459de' target=_blank style='color:#2F92EE;'>#SMO#</a>, objectTitle=2016ESMO临床实践指南——发热性中性粒细胞减少的管理发布, objectType=article, longId=78613, objectId=f8dbe861327, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f8dbe861327, replyNumber=0, likeNumber=39, createdTime=2017-06-03, rootId=0, userName=liuhuangbo, userId=6779163, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f8dbe861327, moduleTitle=2016ESMO临床实践指南——发热性中性粒细胞减少的管理发布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f8dbe861327)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2024758, encodeId=446f2024e58fa, content=<a href='/topic/show?id=c27516459de' target=_blank style='color:#2F92EE;'>#SMO#</a>, objectTitle=近期AASLD/NCCN/ACG/EASL/ESMO肝细胞癌指南解读, objectType=article, longId=72155, objectId=4910e2155ba, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4910e2155ba, replyNumber=0, likeNumber=73, createdTime=2017-01-25, rootId=0, userName=liuhuangbo, userId=6779163, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4910e2155ba, moduleTitle=近期AASLD/NCCN/ACG/EASL/ESMO肝细胞癌指南解读, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4910e2155ba)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2024759, encodeId=5f292024e59af, content=<a href='/topic/show?id=c27516459de' target=_blank style='color:#2F92EE;'>#SMO#</a>, objectTitle=ESMO 18th：Xilonix单药治疗转移性结直肠癌是安全有效的, objectType=article, longId=72221, objectId=8f7de22214e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8f7de22214e, replyNumber=0, likeNumber=76, createdTime=2016-11-10, rootId=0, userName=liuhuangbo, userId=6779163, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8f7de22214e, moduleTitle=ESMO 18th：Xilonix单药治疗转移性结直肠癌是安全有效的, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8f7de22214e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2024755, encodeId=9f8f2024e55df, content=<a href='/topic/show?id=c27516459de' target=_blank style='color:#2F92EE;'>#SMO#</a>, objectTitle=Breast：乳腺癌诊疗指南比较：ESMO V.S NCCN, objectType=article, longId=49383, objectId=0fb7493830f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0fb7493830f, replyNumber=0, likeNumber=60, createdTime=2015-05-27, rootId=0, userName=liuhuangbo, userId=6779163, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0fb7493830f, moduleTitle=Breast：乳腺癌诊疗指南比较：ESMO V.S NCCN, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0fb7493830f)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

SMO

2020-05-29

liuhuangbo (审核中...)

前往app查看评论内容

#SMO#

2016MASCC/ESMO共识建议——高催吐风险化疗恶心呕吐的预防（更新）发布

2017-03-08

liuhuangbo (审核中...)

前往app查看评论内容

#SMO#

ESMO 2016：nivolumab辅助治疗可切除的非小细胞肺癌

2017-02-05

liuhuangbo (审核中...)

前往app查看评论内容

#SMO#

2013ESMO临床实践指南：妊娠滋养细胞疾病的诊断、治疗与随访发布

2016-08-09

liuhuangbo (审核中...)

前往app查看评论内容

#SMO#

ESMO 2016：Alisertib治疗神经内分泌前列腺癌

2017-03-29

liuhuangbo (审核中...)

前往app查看评论内容

#SMO#

2016ESMO临床诊疗指南——胆管癌的诊断、治疗与随访发布

2017-07-28

liuhuangbo (审核中...)

前往app查看评论内容

#SMO#

ESMO 2016：奥拉帕尼能否改善胃癌患者的总生存期？（GOLD试验）

2017-03-17

liuhuangbo (审核中...)

前往app查看评论内容

#SMO#

ESMO 2016：卡铂+培美曲塞+派姆单抗，可改善NSCLC患者的PFS

2017-05-04

liuhuangbo (审核中...)

前往app查看评论内容

#SMO#

ESMO 2016：Niraparib可延长复发性卵巢癌患者的PFS

2017-06-16

liuhuangbo (审核中...)

前往app查看评论内容

#SMO#

2016ESMO临床诊疗指南——新诊断和复发性滤泡性淋巴瘤的诊断、治疗与随访发布

2017-03-25

liuhuangbo (审核中...)

前往app查看评论内容

#SMO#

ESMO 2016：氟维司群可延长乳腺癌患者的无进展生存期（FALCON试验）

2017-01-29

liuhuangbo (审核中...)

前往app查看评论内容

#SMO#

2016ESMO临床实践指南——转移性非小细胞肺癌的诊断、治疗和随访发布

2017-07-19

liuhuangbo (审核中...)

前往app查看评论内容

#SMO#

2016MASCC/ESMO共识建议——中度致吐化疗恶心呕吐的治疗发布

2016-11-13

liuhuangbo (审核中...)

前往app查看评论内容

#SMO#

ESMO 2016：ANG1005可通过血脑屏障，治疗脑转移瘤

2017-03-08

liuhuangbo (审核中...)

前往app查看评论内容

#SMO#

2016ESMO临床实践指南——食管癌的诊断，治疗及随访发布

2016-10-14

liuhuangbo (审核中...)

前往app查看评论内容

#SMO#

2016ESMO临床诊疗指南——BRCA突变携带者以及其他乳腺/卵巢遗传性癌症综合征的预防和筛查发布

2017-05-15

liuhuangbo (审核中...)

前往app查看评论内容

#SMO#

2016MASCC/ESMO共识建议——催吐药风险分类及抗肿瘤药物致吐性评估发布

2017-04-11

liuhuangbo (审核中...)

前往app查看评论内容

#SMO#

2016ESMO临床实践指南——发热性中性粒细胞减少的管理发布

2017-06-03

liuhuangbo (审核中...)

前往app查看评论内容

#SMO#

近期AASLD/NCCN/ACG/EASL/ESMO肝细胞癌指南解读

2017-01-25

liuhuangbo (审核中...)

前往app查看评论内容

#SMO#

ESMO 18th：Xilonix单药治疗转移性结直肠癌是安全有效的

2016-11-10

liuhuangbo (审核中...)

前往app查看评论内容

#SMO#

Breast：乳腺癌诊疗指南比较：ESMO V.S NCCN

2015-05-27

科室
- - 订阅+
  - 更多科室
工具
服务